Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
International Flavors & Fragrances
IFF
|
$159M |
| 2 |
Broadcom
AVGO
|
$140M |
| 3 |
Builders FirstSource
BLDR
|
$128M |
| 4 |
Equinix
EQIX
|
$98.7M |
| 5 |
ConocoPhillips
COP
|
$89.1M |
Top Sells
| 1 |
GameStop
GME
|
$746M |
| 2 |
Chevron
CVX
|
$276M |
| 3 |
Apple
AAPL
|
$238M |
| 4 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
$197M |
| 5 |
CHL
China Mobile Limited
CHL
|
$178M |
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.68% |
| 3 | Industrials | 13.59% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crown Castle
CCI
$43.2B
| $1.03B | 0.34% | 6,000,855 +62,581 | +1% | +$10.8M |
|
27
Procter & Gamble
PG
$368B
| $1.02B | 0.34% | 7,509,843 +58,452 | +0.8% | +$7.92M |
|
28
Thermo Fisher Scientific
TMO
$186B
| $1.01B | 0.33% | 2,207,497 -60,933 | -3% | -$27.8M |
|
29
Morgan Stanley
MS
$240B
| $966M | 0.32% | 12,432,431 +465,330 | +4% | +$36.1M |
|
30
Elevance Health
ELV
$71.8B
| $954M | 0.32% | 2,658,140 -126,423 | -5% | -$45.4M |
|
31
Citigroup
C
$178B
| $940M | 0.31% | 12,924,003 -462,584 | -3% | -$33.7M |
|
32
Micron Technology
MU
$133B
| $921M | 0.3% | 10,433,593 -407,052 | -4% | -$35.9M |
|
33
CVS Health
CVS
$92.8B
| $909M | 0.3% | 12,083,219 -69,215 | -0.6% | -$5.21M |
|
|
34
Chevron
CVX
$324B
| $890M | 0.29% | 8,495,440 -2,634,688 | -24% | -$276M |
|
35
Home Depot
HD
$405B
| $885M | 0.29% | 2,899,958 +76,969 | +3% | +$23.5M |
|
36
General Motors
GM
$55.8B
| $827M | 0.27% | 14,394,184 +84,386 | +0.6% | +$4.85M |
|
37
PepsiCo
PEP
$204B
| $820M | 0.27% | 5,793,522 -18,293 | -0.3% | -$2.59M |
|
|
38
Equinix
EQIX
$76.9B
| $811M | 0.27% | 1,193,559 +145,182 | +14% | +$98.7M |
|
39
Cigna
CI
$80.3B
| $810M | 0.27% | 3,350,163 -82,792 | -2% | -$20M |
|
40
Medtronic
MDT
$119B
| $802M | 0.27% | 6,789,118 -57,443 | -0.8% | -$6.79M |
|
41
Cisco
CSCO
$274B
| $802M | 0.27% | 15,502,015 -451,670 | -3% | -$23.4M |
|
42
AbbVie
ABBV
$372B
| $792M | 0.26% | 7,322,022 +639,017 | +10% | +$69.2M |
|
43
Merck
MRK
$210B
| $782M | 0.26% | 10,146,554 -37,537 | -0.4% | -$2.89M |
|
44
Coca-Cola
KO
$297B
| $782M | 0.26% | 14,829,726 +97,335 | +0.7% | +$5.13M |
|
45
Goldman Sachs
GS
$226B
| $764M | 0.25% | 2,335,061 -26,381 | -1% | -$8.63M |
|
46
Union Pacific
UNP
$133B
| $730M | 0.24% | 3,312,703 -25,302 | -0.8% | -$5.58M |
|
|
47
ConocoPhillips
COP
$124B
| $723M | 0.24% | 13,651,206 +1,682,794 | +14% | +$89.1M |
|
48
Darling Ingredients
DAR
$5.37B
| $711M | 0.24% | 9,661,528 -837,343 | -8% | -$61.6M |
|
49
Accenture
ACN
$162B
| $697M | 0.23% | 2,521,817 +13,175 | +0.5% | +$3.64M |
|
50
Norfolk Southern
NSC
$62.8B
| $697M | 0.23% | 2,594,184 -303,534 | -10% | -$81.5M |
|